Molecular, genetic and stem cell-mediated therapeutic strategies for spinal muscular atrophy (SMA).

ABSTRACT: Spinal muscular atrophy (SMA) is an autosomal recessive motor neuron disease. It is the first genetic cause of infant mortality. It is caused by mutations in the survival motor neuron 1 (SMN1) gene, leading to the reduction of SMN protein. The most striking component is the loss of alpha motor neurons in the ventral horn of the spinal cord, resulting in progressive paralysis and eventually premature death. There is no current treatment other than supportive care, although the past decade has seen a striking advancement in understanding of both SMA genetics and molecular mechanisms. A variety of disease modifying interventions are rapidly bridging the translational gap from the laboratory to clinical trials. In this review, we would like to outline the most interesting therapeutic strategie

SUBMITTER: Zanetta C 

PROVIDER: S-EPMC3930406 | biostudies-literature | 2014 Feb

REPOSITORIES: biostudies-literature